Amplitude Vascular Systems

AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Global executive will lead the clinical research strategy and execution for pulse intravascular lithotripsy BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Elizabeth Galle as the company’s new Vice President of Clinical Affairs. She comes to AVS with more than two decades of leadership experience … Continue reading AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

CroíValve

CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

Additionally, Martin B. Leon, M.D. Appointed as Chair of its Clinical Advisory Board DUBLIN–(BUSINESS WIRE)– CroíValve, an Irish-U.S. based medical device company with a novel, transcatheter solution for tricuspid regurgitation (TR), today announced initiation of its Early Feasibility Study (EFS) for the DUO™ Tricuspid Coaptation Valve System, following FDA IDE and CMS approval. The TANDEM II trial is a prospective, multi-center, non-randomized single-arm study to … Continue reading CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

BIVACOR

BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

HUNTINGTON BEACH, Calif. & HOUSTON & GOLD COAST, Australia–(BUSINESS WIRE)–BiVACOR, Inc., a clinical-stage medical technology company developing a total artificial heart (TAH), today announced that Jim Dillon has been named chief executive officer and a member of its board of directors. “A Total Artificial Heart (TAH) is unique in its complexity and importance as an advanced treatment option for end-stage biventricular heart failure patients. The … Continue reading BiVACOR Names Veteran Medical Device Executive Jim Dillon as Chief Executive Officer

SYNCHRON

Synchron Appoints Riki Banerjee as Chief Technology Officer

NEW YORK–(BUSINESS WIRE)–Synchron, the endovascular brain-computer interface (BCI) company developing technology designed to restore functionality in patients with motor impairment, today announced the appointment of Riki Banerjee, Ph.D., to Chief Technology Officer (CTO). Banerjee will be responsible for leading all research and development (R&D) activities, including advancing Synchron’s neuroprosthesis device for patients with severe paralysis. Banerjee will succeed Nick Opie, Ph.D., the founding CTO and … Continue reading Synchron Appoints Riki Banerjee as Chief Technology Officer

Orthofix

Orthofix Names Massimo Calafiore as President and Chief Executive Officer

Value-Building Medical Device Executive with 20-Year Record of Driving Market-Leading Growth Across Orthopedics and Spine Businesses Global Leader with Extensive M&A Integration Expertise and Commercial and Operating Experience Across Key Orthofix Geographies November 28, 2023 07:00 AM Eastern Standard Time LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo Calafiore has been named incoming President and Chief … Continue reading Orthofix Names Massimo Calafiore as President and Chief Executive Officer

Aerin Medical

Derrick Sung Joins Aerin Medical as Chief Financial Officer

A seasoned leader, Sung brings deep finance, capital markets, and strategy experience across the medical device industry November 20, 2023 09:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Aerin Medical Inc., a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, announced today that Derrick Sung has been appointed chief financial officer of the … Continue reading Derrick Sung Joins Aerin Medical as Chief Financial Officer

CUTERA

Cutera Appoints Stephana Patton as Chief Legal Officer

November 13, 2023 08:30 AM Eastern Standard Time BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Stephana Patton, Ph.D., J.D. as Chief Legal Officer, effective November 13, 2023. “Cutera has a well-established leadership position in the aesthetics industry, and I’m excited to be part of the team that … Continue reading Cutera Appoints Stephana Patton as Chief Legal Officer